Incyte Corporation (INCY)
 NASDAQ: INCY · Real-Time Price · USD
 101.57
 +8.09 (8.65%)
  At close: Nov 3, 2025, 4:00 PM EST
104.00
 +2.43 (2.39%)
  Pre-market: Nov 4, 2025, 7:00 AM EST
Incyte Employees
Incyte had 2,617 employees as of December 31, 2024. The number of employees increased by 93 or 3.68% compared to the previous year.
Employees 
 2,617
Change (1Y) 
 93
Growth (1Y) 
 3.68%
Revenue / Employee 
 $1,839,169
Profits / Employee 
 $454,178
Market Cap 
19.94B
Employees Chart
Employees History
| Date | Employees | Change | Growth | 
|---|---|---|---|
| Dec 31, 2024 | 2,617 | 93 | 3.68% | 
| Dec 31, 2023 | 2,524 | 200 | 8.61% | 
| Dec 31, 2022 | 2,324 | 230 | 10.98% | 
| Dec 31, 2021 | 2,094 | 321 | 18.10% | 
| Dec 31, 2020 | 1,773 | 317 | 21.77% | 
| Dec 31, 2019 | 1,456 | 89 | 6.51% | 
| Dec 31, 2018 | 1,367 | 159 | 13.16% | 
| Dec 31, 2017 | 1,208 | 228 | 23.27% | 
| Dec 31, 2016 | 980 | 288 | 41.62% | 
| Dec 31, 2015 | 692 | 104 | 17.69% | 
| Dec 31, 2014 | 588 | 107 | 22.25% | 
| Dec 31, 2013 | 481 | 68 | 16.46% | 
| Dec 31, 2012 | 413 | 45 | 12.23% | 
| Dec 31, 2011 | 368 | 121 | 48.99% | 
| Dec 31, 2010 | 247 | 26 | 11.76% | 
| Dec 31, 2009 | 221 | 9 | 4.25% | 
| Dec 31, 2008 | 212 | 16 | 8.16% | 
| Dec 31, 2007 | 196 | 10 | 5.38% | 
| Dec 31, 2006 | 186 | 9 | 5.08% | 
| Dec 31, 2005 | 177 | -9 | -4.84% | 
| Dec 31, 2004 | 186 | -268 | -59.03% | 
| Dec 31, 2003 | 454 | -37 | -7.54% | 
| Dec 31, 2002 | 491 | -94 | -16.07% | 
| Dec 31, 2001 | 585 | -737 | -55.75% | 
| Dec 31, 2000 | 1,322 | 214 | 19.31% | 
| Dec 31, 1999 | 1,108 | 241 | 27.80% | 
| Dec 31, 1998 | 867 | 191 | 28.25% | 
| Dec 31, 1997 | 676 | 218 | 47.60% | 
| Dec 31, 1996 | 458 | - | - | 
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees | 
|---|---|
| UnitedHealth Group | 400,000 | 
| Johnson & Johnson | 138,100 | 
| Thermo Fisher Scientific | 125,000 | 
| Abbott Laboratories | 114,000 | 
| AstraZeneca | 92,900 | 
| Novo Nordisk | 77,349 | 
| Novartis AG | 75,883 | 
| Merck & Co. | 75,000 | 
INCY News
- 21 hours ago - Incyte Announces More than 50 Abstracts Accepted for Presentation at the 2025 ASH Annual Meeting - Business Wire
 - 5 days ago - 4 Best Value And Growth Stocks (Yes, They Can Coexist) - Seeking Alpha
 - 5 days ago - Incyte to Present at Upcoming Investor Conferences - Business Wire
 - 5 days ago - Knight Therapeutics Announces Approval and Launch of MINJUVI® (tafasitamab) in Argentina - GlobeNewsWire
 - 6 days ago - Incyte: Maintaining Buy As 2 Untapped Opportunities Emerge In Oncology Portfolio - Seeking Alpha
 - 6 days ago - Incyte Delivers Robust Growth, But 2028 Patent Expiry Still Looms - Benzinga
 - 6 days ago - Incyte Corporation (INCY) Q3 2025 Earnings Call Transcript - Seeking Alpha
 - 7 days ago - Incyte boosts annual sales forecast of blood cancer drug after strong quarter - Reuters